NOLabs won award at MedTech Investment Day for its diabetic pain relief technology.

NOLabs won award at MedTech Investment Day for its diabetic pain relief technology.

MedTech Investment Day Award went to NOLabs

NOLabs, with its NitroSense©Technology for diabetic pain relief, today won the price MedTech Investment Day Award at the MedTech Investment Day on the 4th of December.

Among 19 interesting companies NOLabs is expected to have the greatest potential of becoming an international successful company.

"Fantastic!" A award like this is extremely important and it confirms that we work with the right things." says CEO for NOLabs Mr Göran Beijer. He was very happy and honoured to accept 25 000 Swedish Kronor and a years membership at Swecare, that helps Swedish Companies in healthcare to succeed abroad.

NOLabs NitroSence©Technology makes life for diabetic patients that suffer from peripheral neuropathy easier- a condition that often is very serious and painful. One reason for this condition seams to be a disorder in the human bodies normal production of nitric oxide, with reduced oxygen supply as a serious consequence.

NOLabs develops advanced products that releases a controlled dose of pure nitric oxide that helps the human body to replace the lack of the substance.

"During the first quarter of 2009 we will be working with our Clinical Trials." says Göran Beijer. "When these studies are ready we will begin to start our production, so now we are looking for partners for collaboration and investors.

This is the Jury's motivation why NOLabs got the MedTech Investment Day Award 2008. "NOLabs is a company that uses the dynamic in the medtech directive. The employers are experienced, dedicated and has the knowledge to compliment each other. The company is focusing on its entrance to the market with a broad field of different applications.

The composition of the Jury as follows: Gisela Sitcom, vice regional director at Innovationsbron Mitt, Otto Skolling, Investment Manager at Karolinska Development and Patrik Söderlund, CEO at the Capital Investment Company Lumitec.

This was the first time MedTech Investment Day was held in Kista Science Tower. About 160 people was participating in the event - a collaboration between Swedish MedTech and STING (Stockholm Innovation & Growth). About 30 investors had the opportunity to meet 19 young and promising MedTech companies.

Amongst these companies was Promimic that develops synthetic bones for quicker healing process of the bone structure and Antrad Medical that develops a technique to quickly melt frozen blood plasma and CyberGene who works to analyse the most common chromosome difference in foetus.

During the day interesting speakers shared their best success stories. Amongst the speakers was Christian Kinch from Bactiguard and Peter Selly from Astra Tech.

Medtech Investment Day was sponsored by Innovationsbron, Bird & Bird, Öhrlings PricewaterhouseCoopers, Vinnova, Almi, Clinius, Zacco and Swecare. Their partners was Kista Science City AB and Svenska Riskkapitalföreningen and as a mediapartner MedTech Magazine

Contact persons:
Göran Beijer, CEO, NOLabs AB:

0706-63 60 09, goran.beijer@nolabs.com

Olof Berglund, responsible for the MedTech Investment Day, Swedish Medtech:

070-635 98 15, olof.berglund@swedishmedtech.se